Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-24

FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a generic sustained-release formulation of bupropion hydrochloride for major depressive disorder and seasonal affective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride SR (Bupropion hydrochloride)

Snippet

ORIG AP for BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE)